Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ImmunoGen Company Profile (NASDAQ:IMGN)

Consensus Ratings for ImmunoGen (NASDAQ:IMGN) (?)
Ratings Breakdown: 2 Sell Rating(s), 2 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $17.83 (70.25% upside)

Current Analysts' Coverage Summary for ImmunoGen (NASDAQ:IMGN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/25/2014Morgan StanleyInitiated CoverageUnderweight$10.00ViewTweet This Rating  Share This Rating on StockTwits
4/16/2014Canaccord GenuityInitiated CoverageBuy -> Buy$20.00ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014ZacksUpgradeNeutral -> Outperform$15.90ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014GuggenheimBoost Price Target$14.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013RBC CapitalLower Price TargetOutperform$22.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Chardan CapitalReiterated RatingBuy$21.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Stifel NicolausDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
9/9/2013Jefferies GroupReiterated RatingPositive -> Buy$21.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2013Leerink SwannInitiated CoverageOutperform$24.00ViewTweet This Rating  Share This Rating on StockTwits
8/26/2013Roth CapitalInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2013Credit SuisseBoost Price TargetNeutral$15.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2013Cantor FitzgeraldBoost Price TargetHold$13.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2013Cowen and CompanyReiterated RatingOutperform$20.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013OppenheimerDowngradeOutperform -> Market Perform$14.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2012JPMorgan Chase & Co.Reiterated RatingNeutral -> PositiveViewTweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2012 forward)